Which medication improves fatigue in patients with multiple sclerosis (MS)?: a systematic review and network meta-analysis [0.03%]
改善多发性硬化症患者疲劳的药物有哪些？：系统评价和网状Meta分析
Mohsen Rastkar,Saba Ghandchi,Mahyar Ghajarzadeh et al.
Mohsen Rastkar et al.
Background: Fatigue is a disabling symptom of multiple sclerosis (MS) with an unknown etiology. Various medications are used to treat MS-related fatigue, but none of the available studies directly compared the head-to-hea...
Jill Rasmussen
Jill Rasmussen
Diet and specific nutritional factors, alone and in combination with other lifestyle approaches, have an important role in decreasing the risk for dementia. Protective factors for dementia risk reduction are important in early as well as la...
Baseline epidemiological differences between donanemab and lecanemab users in real-world settings: a retrospective cohort study [0.03%]
在现实世界环境中多纳单抗和仑卡单抗使用者的基线流行病学差异：一项回顾性队列研究
Filipi Fim Andreão,Rebeca Oliveira da Silva,Maria Fernanda Liphaus Almeida Negreli et al.
Filipi Fim Andreão et al.
Aims: Donanemab and Lecanemab are anti-amyloid monoclonal antibodies recently approved for the treatment of Alzheimer's disease. Although their efficacy and safety have been investigated in randomized trials, real-world e...
Targeting excitatory/inhibitory neurotransmission by wogonin: integrated In Silico and In Vivo evidence in Parkinson's disease model [0.03%]
基于中药成分调控神经递质平衡的帕金森病治疗策略：黄芩素作用于帕金森病模型的计算及实验研究
Shivani Chib,Bhaskar Jyoti Dutta,Randhir Singh
Shivani Chib
Aim: The present study aimed to investigate neuroprotective potential of wogonin in rotenone-induced PD, with particular focus on modulation of excitatory/inhibitory (E/I) neurotransmission and other pathological factors,...
J S Sevitz,J A Curtis,N Vanegas-Arroyave et al.
J S Sevitz et al.
Aims: Dysphagia in Progressive Supranuclear Palsy (PSP) has devastating consequences, including pneumonia and death; however, no studies have described its impact on quality of life (QOL), limiting the degree to which man...
Relationship between grip strength, functional outcome, and health-related quality of life measurements in amyotrophic lateral sclerosis patients [0.03%]
肌萎缩侧索硬化患者握力与功能结局及生命质量测量之间的关系
Xiaolu Liu,Dilip Dhakal,Sixin Gu et al.
Xiaolu Liu et al.
Aim: To explore how grip strength is related to functional status and health-related quality of life (HRQoL) in amyotrophic lateral sclerosis (ALS) patients. ...
Pilates as therapy for multiple sclerosis: current perspective and future directions [0.03%]
普拉提作为多发性硬化症治疗的现状和未来方向
Parisa Najafi,Louise Declerck,Robert Motl
Parisa Najafi
Multiple sclerosis (MS) is a disease of the central nervous system (CNS) that often results in walking and balance impairments, fatigue, depression, and reduced quality of life (QOL). Exercise is beneficial for people with MS, and mind-body...
Neuro-reparative potential of hyperbaric oxygen therapy in animal models of Alzheimer's and Parkinson's diseases: systematic review and meta-analysis [0.03%]
高压氧治疗对阿尔茨海默病和帕金森病动物模型的神经修复潜能：系统回顾和荟萃分析
Aiswarya Radhakrishnan,Debprasad Dutta,Moupali Saha et al.
Aiswarya Radhakrishnan et al.
Introduction: This systematic review and meta-analysis explored the efficacy of Hyperbaric oxygen therapy (HBOT) in preclinical models of Alzheimer's disease (AD) and Parkinson's disease (PD). ...
Egor Vinokurov,Ksenia Marinina,Ilya Bezprozvanny
Egor Vinokurov
Spinocerebellar ataxias (SCAs) are a group of neurodegenerative diseases characterized by progressive cerebellar dysfunction, which leads to impaired coordination, dysarthria, oculomotor disorders, and subsequently to a marked reduction in ...
Clinical correlates of global and axial levodopa response in Parkinson's disease [0.03%]
帕金森病左旋多巴全量效应和轴向效应的临床相关性研究
Halil Onder,Meral Oksuz,Ismet Melek et al.
Halil Onder et al.
Background: Levodopa response (LDR) is central to the clinical assessment of Parkinson's disease (PD), yet the factors influencing axial motor responsiveness remain insufficiently explored. ...